Vienna, Austria

ESTRO 2025

Session

Tuesday
May 06
09:15 - 10:30
Mahler
Innovation in healthcare: Who pays?
Mark Gooding, United Kingdom
Drawing from the spirit of ESTRO’s theme 'Transformative innovation through partnership', we will explore how innovation is financed, whether academically or commercially, through to the point of use in the clinic. By considering the cost of research and development and outlining the funding that is required, we will better understand how money flows through the system and appreciate the role each participant has as we collaborate to improve patient care. Short presentations by the various stakeholders in the innovation pipeline will be followed by a panel discussion, giving substantial time to questions from the floor.
Panel Discussion
Interdisciplinary
09:15 - 09:25
Investing for healthcare innovation
Florian Schuster, Germany
E25-4658
09:25 - 09:35
Why do innovative healthcare products cost so much?
Tracy Underwood, United Kingdom
E25-4659
09:35 - 09:45
Is in-house development cost effective?
Peter Remeijer, The Netherlands
E25-4657
09:45 - 09:55
Determining the value of innovation
Miet Vandemaele, Belgium
E25-4660
09:55 - 10:30
Panel discussion